Results from a 6-month study observing BioElectronics’ ActiPatch® musculoskeletal pain therapy device indicated an average 61% reduction in pain for >90% of participants, a decrease in doctor visits, etc.
Initial 12-month efficacy results from a Phase IIA trial demonstrate positive effects on pain and osteoporosis blood markers from a single administration of Bone Therapeutics’ PREOB® autologous osteoblastic cell therapy.
Zimmer Biomet announced that the U.S. DOJ and SEC are continuing evaluation of the company’s past conduct in Brazil and Mexico, regarding possible violations of the Foreign Corrupt Practices Act.
Tenex Health received FDA 510(k) clearance to market the TX2 MicroTip, with application to treat tendinosis of the shoulder and hip in an outpatient procedure. Launch is slated for mid-2016.
aap Implantate sold its biomaterials unit to an undisclosed private equity firm for 36MM (~US $40.3MM). Upon closing, aap will proceed as a pure-play trauma entity.